We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLGO
601
Pelagos Insurance Capital
PLGO
$2.22B
| $666K | ﹤0.01% |
41,084
-787,916
| -95% | -$12.6M |
|
602
ZIM Integrated Shipping Services
ZIM
$2.9B
| $665K | ﹤0.01% |
45,547
+6,189
| +16% | +$116K |
|
|
CTRA
603
DELISTED
Coterra Energy
CTRA
| $661K | ﹤0.01% |
+22,887
| New | +$638K |
|
604
Ternium
TX
$9.68B
| $654K | ﹤0.01% |
20,994
+827
| +4% | +$25K |
|
605
Orthofix Medical
OFIX
$496M
| $649K | ﹤0.01% |
39,789
+297
| +0.8% | +$5.21K |
|
606
Popular Inc
BPOP
$11.1B
| $644K | ﹤0.01% |
6,970
-7,503
| -52% | -$730K |
|
607
Patterson-UTI
PTEN
$3.48B
| $643K | ﹤0.01% |
+78,193
| New | +$656K |
|
|
ECG
608
Everus Construction Group
ECG
$5.98B
| $643K | ﹤0.01% |
+17,328
| New | +$933K |
|
609
Century Communities
CCS
$2.05B
| $615K | ﹤0.01% |
9,171
+314
| +4% | +$22.7K |
|
|
610
Deere & Co
DE
$173B
| $615K | ﹤0.01% |
1,310
-601,818
| -100% | -$282M |
|
|
NTST
611
NETSTREIT Corp
NTST
$2.13B
| $609K | ﹤0.01% |
38,434
+286
| +0.7% | +$4.18K |
|
612
Northeast Community Bancorp
NECB
$380M
| $605K | ﹤0.01% |
25,831
+995
| +4% | +$23.8K |
|
613
Lyft
LYFT
$5.87B
| $604K | ﹤0.01% |
50,903
+1,970
| +4% | +$25.6K |
|
614
Stryker
SYK
$133B
| $601K | ﹤0.01% |
1,615
+14
| +0.9% | +$5.33K |
|
615
Unitil
UTL
$1.01B
| $576K | ﹤0.01% |
9,981
+75
| +0.8% | +$4.13K |
|
616
NWPX Infrastructure Inc
NWPX
$1.22B
| $569K | ﹤0.01% |
13,789
+8,576
| +165% | +$398K |
|
617
Covenant Logistics
CVLG
$1.09B
| $565K | ﹤0.01% |
25,461
+6,193
| +32% | +$160K |
|
618
Monarch Casino & Resort
MCRI
$2.2B
| $557K | ﹤0.01% |
7,159
-515
| -7% | -$43.8K |
|
619
Horizon Bancorp
HBNC
$1.06B
| $555K | ﹤0.01% |
36,797
+273
| +0.7% | +$4.43K |
|
620
Mesa Laboratories
MLAB
$559M
| $553K | ﹤0.01% |
4,663
+36
| +0.8% | +$4.91K |
|
621
Clarivate
CLVT
$1.53B
| $548K | ﹤0.01% |
139,566
-4,227,785
| -97% | -$20M |
|
|
PINE
622
Alpine Income Property Trust
PINE
$337M
| $541K | ﹤0.01% |
32,361
+239
| +0.7% | +$3.95K |
|
623
Ceco Environmental
CECO
$3.94B
| $539K | ﹤0.01% |
+23,641
| New | +$630K |
|
624
TotalEnergies
TTE
$187B
| $534K | ﹤0.01% |
8,247
-25,790
| -76% | -$1.56M |
|
|
NPKI
625
NPK International
NPKI
$1.09B
| $530K | ﹤0.01% |
91,302
-1,775,165
| -95% | -$11.8M |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.